Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 4,558 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: obesity Clear all

Conditions: Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity, TIPS
Interventions: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Sleeve Gastrectomy, Anti-Obesity Pharmacotherapy (Class Effect), Lifestyle Counseling - Diet & Physical-Activity Program; Procedure · Drug · Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2034
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Weight Loss
Interventions: Placebo, VK2735; Drug
Lead sponsor: Viking Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 15
States / cities: Peoria, Arizona • Lake Forest, California • Clearwater, Florida + 12 more

Conditions: Obesity
Interventions: Communications, Pricing, Combined (Communications & Pricing); Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 21 Years to 100 Years
Enrollment: 444 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Feasibility
Interventions: The Papás Saludables, Niños Saludables Program, The Papás Saludables, Niños Saludables Wait-list Control; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 5 Years to 65 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity, Non-Alcoholic Fatty Liver Disease
Interventions: Blood Draw, Stool collection, BodPod Measurement, Liver Ultrasound; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 5 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Obesity
Interventions: Not listed
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 60 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Clinically Severe Obesity, Gastroesophageal Reflux Disease
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 60 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Fresno, California

Conditions: Obesity, Overweight
Interventions: NNC0638-0355, Placebo (NNC0638-0355); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Lenexa, Kansas • San Antonio, Texas • Salt Lake City, Utah

Conditions: Obesity
Interventions: lorcaserin hydrochloride XR, Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 278 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 16
States / cities: Phoenix, Arizona • Bell Gardens, California • Long Beach, California + 13 more

Conditions: Obesity, Morbid
Interventions: F-18 (fallypride); Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Hypertension, Diabetes, Obesity, COPD, CHF, High Cholesterol, Asthma, Chronic Pain, Multiple Sclerosis, Depression, Anxiety, Heart Diseases, Stroke
Interventions: HeRe We Arts, HeRe We Ed; Behavioral
Lead sponsor: Lisa Gallagher; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Euclid, Ohio

Conditions: Obesity
Interventions: Bariatric procedures; Procedure
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Metabolic Syndrome, Non-alcoholic Fatty Liver Disease, Obesity
Interventions: Low-fat diet, Low-carbohydrate diet; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 20 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Atrial Fibrillation, Obesity and Obesity-related Medical Conditions
Interventions: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy, Anti-Obesity Medication (AOM) treatment; Procedure · Drug
Lead sponsor: Ali Aminian; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Sedentary Lifestyle
Interventions: i-STAND, Healthy Living control; Behavioral · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 60 Years to 89 Years
Enrollment: 283 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Infertility, Female
Interventions: Survey & Food Diary; Other
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years to 45 Years · Female only
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Obesity, Dysmobility
Interventions: Multi Modal Balance Training (MMBI), Weight Loss (WL); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Muscle Performance, Sarcopenic Obesity
Interventions: IMM01-STEM, Placebo, IMM01-STEM alternating with placebo (saline); Biological · Other
Lead sponsor: Immunis, Inc.; Industry
Eligibility: 60 Years to 80 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 4
States / cities: Garden Grove, California • Pomona, California • Lenexa, Kansas + 1 more

Conditions: Obesity, Pregnancy Complications, Peripartum Cardiomyopathy
Interventions: NT-proBNP; Diagnostic Test
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Adolescent Obesity, Weight Loss
Interventions: HealthTRAC, SBWC; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 13 Years to 17 Years
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Eugene, Oregon • Portland, Oregon • Providence, Rhode Island

Conditions: Obesity, Type II Diabetes, Cardiovascular Disease, Health Behavior
Interventions: STRIDES, Sham Control; Other
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Haemophilia A, Haemophilia B, Obesity
Interventions: No treatment given; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 317 participants
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Plainsboro, New Jersey

Conditions: Pre Diabetes, Polycystic Ovary Syndrome, Obesity Android
Interventions: Liraglutide Pen Injector [Saxenda], Placebo Liraglutide Pen Injector; Drug
Lead sponsor: Woman's; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Overweight, Obesity
Interventions: NNC0662-0419, Placebo (NNC0662-0419); Drug · Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 19 Years to 55 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Lincoln, Nebraska

Search by objective public record fields.

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

Multi-level Communications and Access Strategies to Improve the Food Environment

Feasibility of Healthy Dads Healthy Kids Latino

Evaluation of Intestinal Microbiome in Obese Kids

Validation and Evaluation of a Portable Body Scanner for Determination of Obesity

Gastric Bypass After Previous Anti-reflux Surgery

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years

PET Imaging and Bariatric Surgery

Arts & Health Education to Improve Health, Resilience, and Well-Being

Endoscopic Sleeve Gastroplasty / Endoscopic Sleeve Gastroplasty

Effect of Dietary Macronutrient Composition

Metabolic Surgery for Atrial Fibrillation Elimination

Healthy Aging Resources to Thrive (HART)

Caloric Intake and Ovarian Reserve

Multimodel Exercise and Weight Loss in Older Obese Veterans With Dysmobility

Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness

NT-proBNP Levels and Obesity in Pregnancy

Teen Weight Control

Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity